Safety/Efficacy of Induction Agents With Tacrolimus, MMF, and Rapid Steroid Withdrawal in Renal Transplant Recipients

NCT00113269 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

501

Enrollment

INDUSTRY

Sponsor class

Conditions

Kidney Transplantation

Interventions

DRUG: basiliximab
DRUG: rabbit anti-thymocyte globulin
DRUG: tacrolimus
DRUG: alemtuzumab
DRUG: mycophenolate mofetil
DRUG: steroids

Sponsor

Astellas Pharma Inc